Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

BCMA (mouse):Fc (human), (recombinant)

 
ALX-522-079-C050 50 µg 377.00 USD
Do you need bulk/larger quantities?
 

Product Specification

Alternative Name:TNFRSF 17, B cell maturation protein, CD269
 
MW:~35kDa (SDS-PAGE).
 
Source:Produced in HEK 293 cells. The extracellular domain of mouse BCMA (aa 1-46) is fused at the C-terminus to a linker peptide (2 aa) and the Fc portion of human IgG1.
 
UniProt ID:O88472
 
Gene/Protein Identifier:A000374 (UCSD Signaling Gateway ID)
 
Concentration:1mg/ml after reconstitution.
 
Formulation:Lyophilized. Contains PBS.
 
Purity:≥90% (SDS-PAGE)
 
Endotoxin Content:<0.1EU/µg purified protein (LAL test; Bio Whittaker).
 
Specificity:Binds mouse and human BAFF and human APRIL.
 
Applications:ELISA, Flow Cytometry, FUNC
 
Application Notes:ELISA: binds to BAFF.
Flow Cytometry: Detection of membrane-bound mouse BAFF and human APRIL in combination with fluorescently labelled Ab to human IgG1.
 
Reconstitution:Reconstitute with 50µl sterile water. Further dilutions should be made with medium containing 5% fetal calf serum or a carrier protein.
 
Shipping:Shipped on Blue Ice
 
Long Term Storage:-20°C
 
Use/Stability:Stable for at least 6 months after receipt when stored at -20°C.
 
Handling:Avoid freeze/thaw cycles. After reconstitution, prepare aliquots and store at -20°C.
 
Technical Info/Product Notes:Historical data has shown that BCMA blocks the binding of mouse BAFF and human APRIL to their receptors BCMA and TACI, inhibiting BAFF and APRIL-mediated splenocyte survival.
 
522-079
Inhibition of rhsBAFF-mediated splenocyte survival.
Figure:
rmBCMA:Fc inhibits rhsBAFF-mediated activation of freshly isolated splenocytes. Concentration of rmBCMA:Fc (Prod. Nr. ALX-522-079) to achieve complete inhibition depends on the concentration of rhsBAFF (Prod. Nr. ALX-522-025) used. A ratio (rhsBAFF:rmBCMA:Fc) 1:50 and higher is recommended.

Method: On day 0 splenocytes were isolated from a freshly collected C57Bl6 spleen. An aliquot of the splenocytes was analyzed on FACS, and B cells were gated on the SSC-FSC panel. FACS settings were saved. The rest of the cells was put in culture with media alone, with the indicated concentration of rhsBAFF alone or in the presence of an excess of rmBCMA:Fc (50µg/ml). After three days in culture, cells were again analyzed on FACS with the saved setting. Splenocytes survival index (=ratio of %living/%dead cells) was calculated and plotted.
Please mouse over
522-079

Product Literature References

Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen: P. Schneider, et al.; J. Exp. Med. 194, 1691 (2001), Abstract; Full Text

Related Products

Control:Fc fusion protein (human), (recombinant) 

Negative control for Fc chimeric proteins
Produced in HEK 293 cells. The extracellular domain of mutated hThy-1, hThy-1 (RLE) (aa 20-130), is fused to the Fc portion of human IgG1. The integrin binding sequence RLD of hThy-1 has been changed to RLE abolishing the binding of integrins., ≥90% (SDS-PAGE) | Print as PDF
 
ALX-203-004-C050 50 µg 405.00 USD
Do you need bulk/larger quantities?
 

Product Toolbox

PRODUCT RESOURCES

Datasheet
MSDS
Certificate of Analysis

RELATED PRODUCTS

By target:
BCMA
By biological activity:
BCMA Recombinant protein
By catalog section:

PRODUCT SUPPORT

FAQs
Technical Service
Customer Service

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,